TGTX - TG Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts6666
Avg. Estimate-0.54-0.53-2.2-2.02
Low Estimate-0.58-0.6-2.36-2.52
High Estimate-0.48-0.47-2.05-0.74
Year Ago EPS-0.48-0.46-1.91-2.2
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts5566
Avg. Estimate30k30k170k21.05M
Low EstimateN/AN/A150k200k
High Estimate40k40k200k64.2M
Year Ago Sales38k38k152k170k
Sales Growth (year/est)-21.10%-21.10%11.80%12,282.40%
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.-0.43-0.44-0.44-0.53
EPS Actual-0.48-0.46-0.59-0.59
Difference-0.05-0.02-0.15-0.06
Surprise %-11.60%-4.50%-34.10%-11.30%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.54-0.53-2.2-2.02
7 Days Ago-0.53-0.53-2.19-1.96
30 Days Ago-0.54-0.55-2.22-1.91
60 Days Ago-0.5-0.5-2.06-1.89
90 Days Ago-0.5-0.5-2.06-1.89
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1111
Growth EstimatesTGTXIndustrySectorS&P 500
Current Qtr.-12.50%N/AN/A0.32
Next Qtr.-15.20%N/AN/A0.43
Current Year-15.20%N/AN/A0.24
Next Year8.20%N/AN/A0.27
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A